What medicine to take after treatment of nasopharyngeal carcinoma

Nasopharyngeal cancer is not unfamiliar to many people. Patients should receive correct and timely treatment during the treatment of nasopharyngeal cancer. The following editor will introduce to you what medicine to take after the treatment of nasopharyngeal cancer?

Due to the hidden anatomical location of the nasopharynx, the early symptoms of nasopharyngeal carcinoma are atypical, and clinical diagnosis is easily delayed, so special vigilance should be exercised. Its common symptoms are:

1. In the early stage of nasal symptoms, there may be blood on the nose due to retraction or blowing, but sometimes there is no such symptoms and the patient does not pay attention to it. As the tumor grows, it may block the nostrils and cause nasal congestion, starting from one side and then both sides.

2. Patients with ear symptoms whose tumors occur in the pharyngeal recess may compress or block the pharyngeal opening of the Eustachian tube in the early stage, leading to tinnitus, ear closure and hearing loss.

There are many drugs to take after nasopharyngeal carcinoma treatment. Here are some of them:

1CBF regimen: 600~10000 mg of cyclophosphamide per time, intravenous injection, applied on days 1 and 4. Bleomycin 15 mg per time, intramuscular injection, applied on days 1 and 5. 5-fluorouracil 5000 mg, intravenous injection, applied on days 2 and 5. Rest after the treatment course, 4 courses per week in total. The efficiency is 60.8%.

2PFA regimen: 20 mg of cisplatin and 500 mg of 5-fluorouracil, intravenous drip for 5 days; 40 mg of doxorubicin, intravenous injection on the first day of treatment. Repeat once after 3 to 4 weeks, can significantly reduce the tumor.

3PF regimen: cisplatin 20mg/m2 and 5-fluorouracil 500mg/m2. Intravenous drip, 5 days and then rest for 2 weeks, 2~3 courses of treatment. This regimen can be used for cases of tumor shrinkage before radiotherapy or simple chemotherapy, with an efficiency of 93.7%.

Through the above introduction, patients can have a clearer understanding of the medications to be taken after treatment of nasopharyngeal cancer.